Mirae Asset Healthcare Fund Regular-IDCW Reinvestment
Mirae Asset Healthcare Fund Regular-IDCW Reinvestment: Mutual Fund Overview
Mirae Asset Healthcare Fund Regular-IDCW Reinvestment is an Sectoral-Pharma mutual fund with over 7.69 years of performance history. The scheme manages an AUM of ₹2843.74 Cr and has a NAV of ₹23.286. It is rated '3' stars by analysts. Investors can begin a SIP with as little as ₹99.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 14.75%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 14.75% at 12 Mar 2026 08:59 PM
Fund Details
NAV 23.286
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount ₹99.0
Fund Age(Year) 7.69
Fund Size(in Crores) 2843.74
Fund Performance
1 Month 3.88%
3 Month 3.55%
6 Month 0.92%
1 Year 14.75%
3 Year 25.79%
5 Year 16.08%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (99.72%) Market Cap Small Cap 25.67 Mid Cap 32.99 Large Cap 41.06 Top Sectors Healthcare 98.16 Chemicals 1.04 Services 0.52 Top Holding Gland Pharma 1.87 JB Chemicals 6.63 Onesource Specialty Pharma 2.43 Sagility 0.52 Aurobindo Pharma 3.92 Laurus Labs 3.56 Sudeep Pharma 0.61 Glenmark Pharmaceuticals 6.93 Biocon 1.44 Lupin 5.15 Syngene International 0 Divi's Laboratories 8.16 Torrent Pharmaceuticals 0.49 Dr. Reddy's Laboratories 4.28 Krishna Institute 3.79 Dr. Lal Pathlabs 1.71 Apollo Hospitals Enterprise 6.38 Rubicon Research 1.02 Wockhardt 0.1 Sai Life Sciences 2.89 Anthem Biosciences 1.3 Aster DM Healthcare 3.33 Alkem Laboratories 3.24 Fortis Healthcare 4.29 Neogen Chemicals 0.53 CORONA Remedies 0.35 Sun Pharmaceutical Industries 11.77 Cipla 4.83 Mankind Pharma 1.81 Deepak Nitrite 0.51 Eris Lifesciences 2.71 Ipca Laboratories 3.18
Debt & Others (0.28%) Sector Allocation Mutual Fund 0.01 Repo 0.73 Net Payables -0.46 Debt Credit Ratings Debt Category Others 0.27 Mirae Asset Liquid Direct-G 0.01
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.92%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Vrijesh Kasera
Education Mr. Kasera is a MBA (Finance), CFA (ICFAI).
Experience Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Tanmay Mehta
Education B.Com, C.A.
Experience Prior to joining the Mirae asset MF, he was associated with SBI capital markets.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 1
Date of Incorporation 2018-07-02
Total AUM 224201.22
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
